Bristol-Myers Squibb Company

Program Leader Early Stage Oncology Assets

Location
Princeton, NJ, US
Posted
Oct 13, 2018
Ref
R1509454
Required Education
Doctorate/PHD/MD
Position Type
Full time
Program Leader Early Stage Oncology Assets

Bristol-Myers Squibb is actively conducting translational medicine research to further our understanding of cancer biology and to identify which patient populations may be more likely to derive benefit from Immuno-Oncology (I-O). Bristol-Myers Squibb has long believed the future of cancer research is dependent on investments in science and partnerships. Collaboration is integrated into our organizational framework across translational medicine and R&D.

The Program Leader is responsible for leading a team that will develop and execute the translational strategies for the early assets in BMS' Oncology pipeline. This person will lead a team of translational medicine team leads (TMTLs) and biomarker scientists who are responsible for the translation plans of the assets in early clinical development.

The candidate will be responsible for understanding the external research environment, and incorporating findings into the strategic plans. This candidate will also partner closely with the discovery biology and the early clinical development groups. They will lead also chair a steering committee to align on key datasets and issues across these interfaces. Specifically, this person will:

  • Manage oversight of the translational strategy for the early assets portfolio
  • Proactively develop talent across the organization and leverages external network to connect others with hiring needs.
  • Create opportunities for others within and outside of own team to develop new skills and experience.
  • Build and maintain networks within and outside of the organization to both strengthen their understanding of the big picture and leverage diverse perspectives, experiences and expertise to maximize performance.
  • Independently engage with development teams, technical/scientific experts, governance bodies, and advisory boards to define, revise and progress biomarker strategies.
  • Proactively provides insight into novel ways to incorporate biomarkers into clinical designs to enable early understanding of emerging drug profiles.
  • Effectively interface across the Translational Medicine organization to obtain appropriate resources to deliver on biomarker goals.
  • Collaborate and strategize across the entire Oncology organization to improve efficiency and accelerate the product pipeline forward.
  • As appropriate, provide biomarker expertise to progress validated biomarkers into development of pharmacodiagnostic tools.


This position reports to the Head of Precision Medicine and will be based in Lawrenceville, New Jersey.

Qualifications:
  • MD or PhD, or equivalent advanced biology degree
  • Experienced scientist with 10+ years' experience in the drug development process and 3+ year's people management experience.
  • Deep understanding of the role of translational research/medicine and clinical biomarkers in drug development
  • Excellent communication skills across all levels within an organization and external.
  • Experienced manager of people and projects including demonstrated ability to grow new leaders and delegate key projects appropriately.
  • Comfortable working in a fast-paced environment where speed needs to be balanced with excellence in execution.
  • Willing to work as a topic expert, outside of a traditional functional environment, in a team unified around serving the assets
  • Ability to recognize, articulate, and accept calculated risks to make informed decisions
  • Willingness and ability to effectively cooperate and partner with external providers and others within BMS
  • Demonstrated experience in the appropriate application of various scientific technologies into translational research strategies
  • Working knowledge of all functional areas of drug development, including, biology, toxicology, clinical development, diagnostic development, etc.
  • Demonstrated scientific acumen and mechanistic understanding of disease biology